Clinical Impact of Radiotherapy in Steroid-Refractory Graves' Orbitopathy

Cureus·Apr 25

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research is being conducted on the clinical impact of radiotherapy in treating steroid-refractory graves' orbitopathy. Various studies and updates are exploring different therapeutic approaches, including pharmacological interventions and radiation therapy, for the management of thyroid eye disease. The role of radiotherapy in treating thyroid-associated ophthalmopathy is being examined, with some studies investigating its efficacy and predictive factors for treatment response.

Full coverage

Emerging therapeutic approaches in graves’ ophthalmopathy: an update on pharmacological interventions

Frontiers·Jul 25

The changing landscape of thyroid eye disease: current clinical advances and future outlook

Nature·Feb 19

Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management

The Lancet·May 2

Treatment of Graves’ ophthalmopathy

www.elsevier.com·Jan 28

Novel perspectives on the pharmacological treatment of thyroid-associated ophthalmopathy

Frontiers·Dec 23

Thyroid eye disease: Primary care recognition and referral

Royal Australian College of General Practitioners (RACGP)·Jun 30

The efficacy of intensity modulated radiation therapy in treating thyroid-associated ophthalmopathy and predictive factors for treatment response

Nature·Dec 13

Thyroid orbitopathy, an overview with special attention to the role of radiotherapy

www.elsevier.com·Mar 31

View original report at Cureus ↗

Fetching the latest headlines…